These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 3078739)

  • 1. Non-replicating oral whole cell vaccine protective against enterotoxigenic Escherichia coli (ETEC) diarrhea: stimulation of anti-CFA (CFA/I) and anti-enterotoxin (anti-LT) intestinal IgA and protection against challenge with ETEC belonging to heterologous serotypes.
    Evans DG; Evans DJ; Opekun AR; Graham DY
    FEMS Microbiol Immunol; 1988 Dec; 1(3):117-25. PubMed ID: 3078739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoprotective oral whole cell vaccine for enterotoxigenic Escherichia coli diarrhea prepared by in situ destruction of chromosomal and plasmid DNA with colicin E2.
    Evans DJ; Evans DG; Opekun AR; Graham DY
    FEMS Microbiol Immunol; 1988 Jan; 1(1):9-18. PubMed ID: 3078575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuated Escherichia coli strains expressing the colonization factor antigen I (CFA/I) and a detoxified heat-labile enterotoxin (LThK63) enhance clearance of ETEC from the lungs of mice and protect mice from intestinal ETEC colonization and LT-induced fluid accumulation.
    Byrd W; Boedeker EC
    Vet Immunol Immunopathol; 2013 Mar; 152(1-2):57-67. PubMed ID: 23122616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.
    Holmgren J; Bourgeois L; Carlin N; Clements J; Gustafsson B; Lundgren A; Nygren E; Tobias J; Walker R; Svennerholm AM
    Vaccine; 2013 May; 31(20):2457-64. PubMed ID: 23541621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of purified colonization factor antigens (CFA/I, CFA/II) of enterotoxigenic Escherichia coli to volunteers. Response to challenge with virulent enterotoxigenic Escherichia coli.
    Evans DG; Graham DY; Evans DJ
    Gastroenterology; 1984 Oct; 87(4):934-40. PubMed ID: 6381216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge study.
    McKenzie R; Bourgeois AL; Frech SA; Flyer DC; Bloom A; Kazempour K; Glenn GM
    Vaccine; 2007 May; 25(18):3684-91. PubMed ID: 17313998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adhesion of enterotoxigenic Escherichia coli in humans and animals.
    Levine MM
    Ciba Found Symp; 1981; 80():142-60. PubMed ID: 6114818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intramuscularly Administered Enterotoxigenic
    Upadhyay I; Lauder KL; Li S; Ptacek G; Zhang W
    Microbiol Spectr; 2022 Aug; 10(4):e0147322. PubMed ID: 35762781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enterotoxigenic Escherichia coli Adhesin-Toxoid Multiepitope Fusion Antigen CFA/I/II/IV-3xSTa
    Nandre R; Ruan X; Lu T; Duan Q; Sack D; Zhang W
    Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29263112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enteral immunization and challenge of volunteers given enterotoxigenic E. coli CFA/II encapsulated in biodegradable microspheres.
    Tacket CO; Reid RH; Boedeker EC; Losonsky G; Nataro JP; Bhagat H; Edelman R
    Vaccine; 1994 Nov; 12(14):1270-4. PubMed ID: 7856290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent circulating immunoglobulin A antibody-secreting cell and serum antibody responses in Swedish volunteers to an oral inactivated enterotoxigenic Escherichia coli vaccine.
    Jertborn M; Ahrén C; Svennerholm AM
    Clin Diagn Lab Immunol; 2001 Mar; 8(2):424-8. PubMed ID: 11238232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal antibody response after oral immunization with a prototype cholera B subunit-colonization factor antigen enterotoxigenic Escherichia coli vaccine.
    Ahrén C; Wennerås C; Holmgren J; Svennerholm AM
    Vaccine; 1993; 11(9):929-34. PubMed ID: 8212839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of piglets against enteric colibacillosis by intranasal immunization with K88ac (F4ac) fimbriae and heat labile enterotoxin of Escherichia coli.
    Lin J; Mateo KS; Zhao M; Erickson AK; Garcia N; He D; Moxley RA; Francis DH
    Vet Microbiol; 2013 Mar; 162(2-4):731-739. PubMed ID: 23089483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A tripartite fusion, FaeG-FedF-LT(192)A2:B, of enterotoxigenic Escherichia coli (ETEC) elicits antibodies that neutralize cholera toxin, inhibit adherence of K88 (F4) and F18 fimbriae, and protect pigs against K88ac/heat-labile toxin infection.
    Ruan X; Liu M; Casey TA; Zhang W
    Clin Vaccine Immunol; 2011 Oct; 18(10):1593-9. PubMed ID: 21813665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response to Escherichia coli antigens entrapped in liposomes. I. Immunopathological studies.
    Dima VF; Popescu C; Postoarcă A; Ionescu MD; Oproiu G; Lacky D; Balotescu C; Dima SV
    Roum Arch Microbiol Immunol; 1999; 58(3-4):223-39. PubMed ID: 11845460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral immunization of rabbits with enterotoxigenic Escherichia coli protects against intraintestinal challenge.
    Sack RB; Kline RL; Spira WM
    Infect Immun; 1988 Feb; 56(2):387-94. PubMed ID: 3276624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serologic correlates of protection against enterotoxigenic Escherichia coli diarrhea.
    Rao MR; Wierzba TF; Savarino SJ; Abu-Elyazeed R; El-Ghoreb N; Hall ER; Naficy A; Abdel-Messih I; Frenck RW; Svennerholm AM; Clemens JD
    J Infect Dis; 2005 Feb; 191(4):562-70. PubMed ID: 15655780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Avirulent K88 (F4)+ Escherichia coli strains constructed to express modified enterotoxins protect young piglets from challenge with a virulent enterotoxigenic Escherichia coli strain that expresses the same adhesion and enterotoxins.
    Santiago-Mateo K; Zhao M; Lin J; Zhang W; Francis DH
    Vet Microbiol; 2012 Oct; 159(3-4):337-42. PubMed ID: 22541162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen-specific memory B-cell responses to enterotoxigenic Escherichia coli infection in Bangladeshi adults.
    Alam MM; Aktar A; Afrin S; Rahman MA; Aktar S; Uddin T; Rahman MA; Al Mahbuba D; Chowdhury F; Khan AI; Bhuiyan TR; Begum YA; Ryan ET; Calderwood SB; Svennerholm AM; Qadri F
    PLoS Negl Trop Dis; 2014 Apr; 8(4):e2822. PubMed ID: 24762744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MecVax supplemented with CFA MEFA-II induces functional antibodies against 12 adhesins (CFA/I, CS1-CS7, CS12, CS14, CS17, and CS21) and 2 toxins (STa, LT) of enterotoxigenic
    Zhang C; Li S; Upadhyay I; Lauder KL; Sack DA; Zhang W
    Microbiol Spectr; 2024 Apr; 12(4):e0415323. PubMed ID: 38364078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.